ABVAX Performance — AB Large Cap Value Fund, Class A
Data updated: 2026-09-11
ABVAX returned +19.12% year to date and +33.83% over one year to Jun 2026. Annualised returns are +19.41% over 3 years and +13.17% over 5 years. The fund beat its US Large Value category average: $100 invested three years ago grew to $170, against $158 for the category, and to $134 over one year, against $121. Volatility over the past three years was 13.76% a year. In the 12 months to Jun 2026 the fund took in a net $1.2M, and assets reached $529.40M.
ABVAX Growth of $100
What $100 invested in AB Large Cap Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | ABVAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $134 | $121 |
| 3 years (Jul 2023 – Jun 2026) | $170 | $158 |
| 5 years (Jul 2021 – Jun 2026) | $186 | $165 |
| Since data start (Sep 2019 – Jun 2026) | $252 | $225 |
ABVAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +19.12% |
| 1 year | +33.83% |
| 3 years (annualised) | +19.41% |
| 5 years (annualised) | +13.17% |
ABVAX Annual Returns
Calendar-year total returns of AB Large Cap Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +19.12% |
| 2025 | +16.72% |
| 2024 | +15.58% |
| 2023 | +18.49% |
| 2022 | −7.03% |
| 2021 | +27.03% |
| 2020 | +0.92% |
| 2019 (Sep–Dec) | +11.07% |
ABVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +7.3% | +2.1% | −5.0% | +7.2% | +1.3% | +5.4% | — | — | — | — | — | — |
| 2025 | +5.5% | −0.1% | −4.2% | −4.7% | +3.1% | +4.6% | +1.5% | +2.9% | +3.1% | +1.1% | +2.6% | +0.6% |
| 2024 | +0.7% | +4.4% | +5.8% | −4.2% | +3.1% | −0.5% | +3.5% | +1.3% | +2.2% | −0.3% | +7.5% | −7.9% |
| 2023 | +9.1% | −3.0% | −0.5% | +1.4% | −2.8% | +7.8% | +3.5% | −2.4% | −3.8% | −3.4% | +7.8% | +4.7% |
| 2022 | −1.6% | −1.3% | +2.3% | −5.2% | +2.1% | −8.5% | +6.7% | −1.2% | −9.3% | +10.3% | +5.5% | −5.1% |
| 2021 | −1.0% | +9.2% | +6.4% | +4.8% | +3.1% | −2.5% | +0.4% | +1.8% | −4.2% | +5.1% | −3.4% | +5.5% |
| 2020 | −2.7% | −10.1% | −17.8% | +11.8% | +3.4% | −0.4% | +4.0% | +3.5% | −3.4% | −1.4% | +14.0% | +4.4% |
| 2019 | — | — | — | — | — | — | — | — | +4.9% | +1.4% | +1.7% | +2.6% |
ABVAX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.76%
- 3-year Sharpe ratio: 1.08 (vs 4.5% risk-free rate)
- Best month: +7.81% (Nov 2023)
- Worst month: −7.90% (Dec 2024)
ABVAX Fund Flows
Monthly money in and out of AB Large Cap Value Fund, from SEC Form N-PORT.
- 12-month net flow: $1.2M
- 12-month gross sales (incl. reinvestments): $85.0M
- Sales ÷ redemptions: 1.01×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $4.0M | $9.9M | −$6.0M |
| May 2026 | $4.0M | $8.2M | −$4.2M |
| Apr 2026 | $4.5M | $5.3M | −$775K |
| Mar 2026 | $19.6M | $7.0M | $12.6M |
| Feb 2026 | $2.5M | $4.5M | −$2.0M |
| Jan 2026 | $2.2M | $9.3M | −$7.1M |
| Dec 2025 | $41.2M | $5.6M | $35.6M |
| Nov 2025 | $1.3M | $5.0M | −$3.7M |
| Oct 2025 | $1.8M | $4.2M | −$2.5M |
| Sep 2025 | $1.5M | $5.5M | −$4.0M |
| Aug 2025 | $1.1M | $2.6M | −$1.5M |
| Jul 2025 | $1.3M | $16.4M | −$15.2M |
ABVAX Assets Under Management
Net assets of AB Large Cap Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $529.40M |
| 2026-05-31 | $507.99M |
| 2026-02-28 | $483.49M |
| 2025-11-30 | $452.67M |
| 2025-08-31 | $433.09M |
| 2025-05-31 | $415.81M |
| 2025-02-28 | $455.01M |
| 2024-11-30 | $480.22M |
| 2024-08-31 | $450.59M |
| 2024-05-31 | $428.80M |
| 2024-02-29 | $425.82M |
| 2023-11-30 | $391.69M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.